vs
Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and SOLESENCE, INC. (SLSN). Click either name above to swap in a different company.
ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $12.5M, roughly 1.8× SOLESENCE, INC.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -0.7%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 12.5%).
ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.
ADCT vs SLSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.1M | $12.5M |
| Net Profit | — | $163.0K |
| Gross Margin | — | 27.5% |
| Operating Margin | -77.7% | 1.5% |
| Net Margin | — | 1.3% |
| Revenue YoY | 36.4% | -0.7% |
| Net Profit YoY | — | 129.2% |
| EPS (diluted) | $0.04 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.1M | $12.5M | ||
| Q3 25 | $15.8M | $14.6M | ||
| Q2 25 | $18.1M | $20.4M | ||
| Q1 25 | $17.4M | $14.6M | ||
| Q4 24 | $16.9M | $12.6M | ||
| Q3 24 | $18.0M | $16.9M | ||
| Q2 24 | $17.0M | $13.0M | ||
| Q1 24 | $17.8M | $9.9M |
| Q4 25 | — | $163.0K | ||
| Q3 25 | $-41.0M | $-1.1M | ||
| Q2 25 | $-56.6M | $2.7M | ||
| Q1 25 | $-38.6M | $80.0K | ||
| Q4 24 | — | $-559.0K | ||
| Q3 24 | $-44.0M | $3.0M | ||
| Q2 24 | $-36.5M | $856.0K | ||
| Q1 24 | $-46.6M | $893.0K |
| Q4 25 | — | 27.5% | ||
| Q3 25 | — | 23.1% | ||
| Q2 25 | — | 28.9% | ||
| Q1 25 | — | 23.1% | ||
| Q4 24 | — | 22.0% | ||
| Q3 24 | — | 36.2% | ||
| Q2 24 | — | 28.7% | ||
| Q1 24 | — | 36.3% |
| Q4 25 | -77.7% | 1.5% | ||
| Q3 25 | -196.6% | -5.4% | ||
| Q2 25 | -244.1% | 9.4% | ||
| Q1 25 | -163.5% | 1.8% | ||
| Q4 24 | -191.8% | -1.8% | ||
| Q3 24 | -197.4% | 19.0% | ||
| Q2 24 | -170.5% | 8.0% | ||
| Q1 24 | -188.3% | 11.3% |
| Q4 25 | — | 1.3% | ||
| Q3 25 | -260.1% | -7.7% | ||
| Q2 25 | -313.2% | 13.1% | ||
| Q1 25 | -221.8% | 0.5% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | -244.1% | 18.1% | ||
| Q2 24 | -214.6% | 6.6% | ||
| Q1 24 | -261.1% | 9.0% |
| Q4 25 | $0.04 | $0.00 | ||
| Q3 25 | $-0.30 | $-0.02 | ||
| Q2 25 | $-0.50 | $0.04 | ||
| Q1 25 | $-0.36 | $0.00 | ||
| Q4 24 | $-0.26 | $0.00 | ||
| Q3 24 | $-0.42 | $0.04 | ||
| Q2 24 | $-0.38 | $0.01 | ||
| Q1 24 | $-0.56 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $261.3M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-185.8M | $17.6M |
| Total Assets | $323.1M | $50.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $261.3M | $1.3M | ||
| Q3 25 | $234.7M | $429.0K | ||
| Q2 25 | $264.6M | $4.1M | ||
| Q1 25 | $194.7M | $1.8M | ||
| Q4 24 | $250.9M | $1.4M | ||
| Q3 24 | $274.3M | $2.9M | ||
| Q2 24 | $300.1M | $2.4M | ||
| Q1 24 | $234.3M | $2.0M |
| Q4 25 | $-185.8M | $17.6M | ||
| Q3 25 | $-238.2M | $17.2M | ||
| Q2 25 | $-199.2M | $18.2M | ||
| Q1 25 | $-238.2M | $15.2M | ||
| Q4 24 | $-202.6M | $14.9M | ||
| Q3 24 | $-171.9M | $15.2M | ||
| Q2 24 | $-131.7M | $11.9M | ||
| Q1 24 | $-194.4M | $5.0M |
| Q4 25 | $323.1M | $50.1M | ||
| Q3 25 | $289.8M | $54.0M | ||
| Q2 25 | $321.6M | $60.0M | ||
| Q1 25 | $272.5M | $57.0M | ||
| Q4 24 | $322.0M | $50.0M | ||
| Q3 24 | $349.1M | $48.0M | ||
| Q2 24 | $371.8M | $40.8M | ||
| Q1 24 | $308.0M | $38.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.1M | $1.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 11.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.1M | $1.8M | ||
| Q3 25 | $-29.6M | $-2.5M | ||
| Q2 25 | $-24.1M | $-654.0K | ||
| Q1 25 | $-56.3M | $-7.2M | ||
| Q4 24 | $-21.9M | $2.2M | ||
| Q3 24 | $-25.0M | $4.2M | ||
| Q2 24 | $-32.8M | $-565.0K | ||
| Q1 24 | $-44.1M | $-3.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-56.6M | — | ||
| Q4 24 | $-21.9M | $-404.0K | ||
| Q3 24 | $-25.3M | $2.8M | ||
| Q2 24 | $-32.9M | $-1.0M | ||
| Q1 24 | $-44.6M | $-3.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -325.2% | — | ||
| Q4 24 | -129.8% | -3.2% | ||
| Q3 24 | -140.2% | 16.6% | ||
| Q2 24 | -193.0% | -8.0% | ||
| Q1 24 | -250.0% | -39.9% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 0.5% | 20.6% | ||
| Q3 24 | 1.2% | 8.3% | ||
| Q2 24 | 0.2% | 3.7% | ||
| Q1 24 | 3.0% | 0.9% |
| Q4 25 | — | 11.16× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.25× | ||
| Q1 25 | — | -90.26× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.38× | ||
| Q2 24 | — | -0.66× | ||
| Q1 24 | — | -4.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
